Clostridium Diagnostics Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 08: Executive Summary - Chart on Incremental Growth
Exhibit 09: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 11: Parent market
Exhibit 12: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 13: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 14: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global clostridium diagnostics market 2017 - 2021
Exhibit 19: Historic Market Size - Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)
4.2 Technology Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 End user Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - End user Segment 2017 - 2021 ($ million)
4.5 Geography Segment Analysis 2017 - 2021
Exhibit 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.6 Country Segment Analysis 2017 - 2021
Exhibit 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 28: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 29: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 30: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology
6.1 Market segments
Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
6.2 Comparison by Technology
Exhibit 34: Chart on Comparison by Technology
Exhibit 35: Data Table on Comparison by Technology
6.3 Immunoassays - Market size and forecast 2022-2027
Exhibit 36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibit 39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)
6.4 Molecular diagnostics - Market size and forecast 2022-2027
Exhibit 40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Technology
Exhibit 44: Market opportunity by Technology ($ million)
Exhibit 45: Data Table on Market opportunity by Technology ($ million)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 46: Chart on Product - Market share 2022-2027 (%)
Exhibit 47: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 48: Chart on Comparison by Product
Exhibit 49: Data Table on Comparison by Product
7.3 Clostridium difficile - Market size and forecast 2022-2027
Exhibit 50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)
7.4 Clostridium perfringens - Market size and forecast 2022-2027
Exhibit 54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibit 57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
7.5 Clostridium botulinum - Market size and forecast 2022-2027
Exhibit 58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibit 61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
7.6 Clostridium tetani - Market size and forecast 2022-2027
Exhibit 62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)
7.7 Clostridium sordellii - Market size and forecast 2022-2027
Exhibit 66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Product
Exhibit 70: Market opportunity by Product ($ million)
Exhibit 71: Data Table on Market opportunity by Product ($ million)

8 Market Segmentation by End-user
8.1 Market segments
Exhibit 72: Chart on End-user - Market share 2022-2027 (%)
Exhibit 73: Data Table on End-user - Market share 2022-2027 (%)
8.2 Comparison by End-user
Exhibit 74: Chart on Comparison by End-user
Exhibit 75: Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2022-2027
Exhibit 76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
8.4 Independent laboratories - Market size and forecast 2022-2027
Exhibit 80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)
8.5 Physicians clinics - Market size and forecast 2022-2027
Exhibit 84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibit 87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)
8.6 Market opportunity by End-user
Exhibit 88: Market opportunity by End-user ($ million)
Exhibit 89: Data Table on Market opportunity by End-user ($ million)

9 Customer Landscape
9.1 Customer landscape overview
Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape
10.1 Geographic segmentation
Exhibit 91: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
10.2 Geographic comparison
Exhibit 93: Chart on Geographic comparison
Exhibit 94: Data Table on Geographic comparison
10.3 North America - Market size and forecast 2022-2027
Exhibit 95: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on North America - Year-over-year growth 2022-2027 (%)
10.4 Europe - Market size and forecast 2022-2027
Exhibit 99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Europe - Year-over-year growth 2022-2027 (%)
10.5 Asia - Market size and forecast 2022-2027
Exhibit 103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Asia - Year-over-year growth 2022-2027 (%)
10.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
10.7 US - Market size and forecast 2022-2027
Exhibit 111: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2022-2027 (%)
10.8 Germany - Market size and forecast 2022-2027
Exhibit 115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 117: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Germany - Year-over-year growth 2022-2027 (%)
10.9 UK - Market size and forecast 2022-2027
Exhibit 119: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 121: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 122: Data Table on UK - Year-over-year growth 2022-2027 (%)
10.10 China - Market size and forecast 2022-2027
Exhibit 123: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 124: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 125: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 126: Data Table on China - Year-over-year growth 2022-2027 (%)
10.11 Canada - Market size and forecast 2022-2027
Exhibit 127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 129: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 130: Data Table on Canada - Year-over-year growth 2022-2027 (%)
10.12 Market opportunity By Geographical Landscape
Exhibit 131: Market opportunity By Geographical Landscape ($ million)
Exhibit 132: Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Trends
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Exhibit 133: Impact of drivers and challenges in 2022 and 2027
11.4 Market trends

12 Vendor Landscape
12.1 Overview
12.2 Vendor landscape
Exhibit 134: Overview on Criticality of inputs and Factors of differentiation
12.3 Landscape disruption
Exhibit 135: Overview on factors of disruption
12.4 Industry risks
Exhibit 136: Impact of key risks on business

13 Vendor Analysis
13.1 Vendors covered
Exhibit 137: Vendors covered
13.2 Market positioning of vendors
Exhibit 138: Matrix on vendor position and classification
13.3 AstraZeneca Plc
Exhibit 139: AstraZeneca Plc - Overview
Exhibit 140: AstraZeneca Plc - Product/Service
Exhibit 141: AstraZeneca Plc - Key news
Exhibit 142: AstraZeneca Plc - Key offerings
13.4 Becton Dickinson and Co.
Exhibit 143: Becton Dickinson and Co. - Overview
Exhibit 144: Becton Dickinson and Co. - Business segments
Exhibit 145: Becton Dickinson and Co. - Key news
Exhibit 146: Becton Dickinson and Co. - Key offerings
Exhibit 147: Becton Dickinson and Co. - Segment focus
13.5 bioMerieux SA
Exhibit 148: bioMerieux SA - Overview
Exhibit 149: bioMerieux SA - Product/Service
Exhibit 150: bioMerieux SA - Key offerings
13.6 DiaSorin SpA
Exhibit 151: DiaSorin SpA - Overview
Exhibit 152: DiaSorin SpA - Business segments
Exhibit 153: DiaSorin SpA - Key news
Exhibit 154: DiaSorin SpA - Key offerings
Exhibit 155: DiaSorin SpA - Segment focus
13.7 F. Hoffmann La Roche Ltd.
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
13.8 Ferring BV
Exhibit 161: Ferring BV - Overview
Exhibit 162: Ferring BV - Product/Service
Exhibit 163: Ferring BV - Key offerings
13.9 Fujirebio Holdings Inc.
Exhibit 164: Fujirebio Holdings Inc. - Overview
Exhibit 165: Fujirebio Holdings Inc. - Product/Service
Exhibit 166: Fujirebio Holdings Inc. - Key offerings
13.10 Hologic Inc.
Exhibit 167: Hologic Inc. - Overview
Exhibit 168: Hologic Inc. - Business segments
Exhibit 169: Hologic Inc. - Key news
Exhibit 170: Hologic Inc. - Key offerings
Exhibit 171: Hologic Inc. - Segment focus
13.11 Huvepharma
Exhibit 172: Huvepharma - Overview
Exhibit 173: Huvepharma - Product/Service
Exhibit 174: Huvepharma - Key offerings
13.12 Novartis AG
Exhibit 175: Novartis AG - Overview
Exhibit 176: Novartis AG - Business segments
Exhibit 177: Novartis AG - Key offerings
Exhibit 178: Novartis AG - Segment focus
13.13 Olympus Corp.
Exhibit 179: Olympus Corp. - Overview
Exhibit 180: Olympus Corp. - Business segments
Exhibit 181: Olympus Corp. - Key news
Exhibit 182: Olympus Corp. - Key offerings
Exhibit 183: Olympus Corp. - Segment focus
13.14 Pfizer Inc.
Exhibit 184: Pfizer Inc. - Overview
Exhibit 185: Pfizer Inc. - Product/Service
Exhibit 186: Pfizer Inc. - Key news
Exhibit 187: Pfizer Inc. - Key offerings
13.15 QIAGEN NV
Exhibit 188: QIAGEN NV - Overview
Exhibit 189: QIAGEN NV - Product/Service
Exhibit 190: QIAGEN NV - Key news
Exhibit 191: QIAGEN NV - Key offerings
13.16 Siemens AG
Exhibit 192: Siemens AG - Overview
Exhibit 193: Siemens AG - Business segments
Exhibit 194: Siemens AG - Key news
Exhibit 195: Siemens AG - Key offerings
Exhibit 196: Siemens AG - Segment focus
13.17 Thermo Fisher Scientific Inc.
Exhibit 197: Thermo Fisher Scientific Inc. - Overview
Exhibit 198: Thermo Fisher Scientific Inc. - Business segments
Exhibit 199: Thermo Fisher Scientific Inc. - Key news
Exhibit 200: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 201: Thermo Fisher Scientific Inc. - Segment focus

14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Exhibit 202: Inclusions checklist
Exhibit 203: Exclusions checklist
14.3 Currency conversion rates for US$
Exhibit 204: Currency conversion rates for US$
14.4 Research methodology
Exhibit 205: Research methodology
Exhibit 206: Validation techniques employed for market sizing
Exhibit 207: Information sources
14.5 List of abbreviations
Exhibit 208: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Vendor Market Positioning
Exhibits 11: Parent market
Exhibits 12: Market Characteristics
Exhibits 13: Offerings of vendors included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 19: Historic Market Size - Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - End user Segment 2017 - 2021 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2022 and 2027
Exhibits 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 29: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 30: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 31: Chart on Market condition - Five forces 2022 and 2027
Exhibits 32: Chart on Technology - Market share 2022-2027 (%)
Exhibits 33: Data Table on Technology - Market share 2022-2027 (%)
Exhibits 34: Chart on Comparison by Technology
Exhibits 35: Data Table on Comparison by Technology
Exhibits 36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibits 37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibits 38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibits 39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibits 40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 44: Market opportunity by Technology ($ million)
Exhibits 45: Data Table on Market opportunity by Technology ($ million)
Exhibits 46: Chart on Product - Market share 2022-2027 (%)
Exhibits 47: Data Table on Product - Market share 2022-2027 (%)
Exhibits 48: Chart on Comparison by Product
Exhibits 49: Data Table on Comparison by Product
Exhibits 50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibits 54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibits 55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibits 57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibits 58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibits 59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibits 61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibits 62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibits 65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibits 66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibits 69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibits 70: Market opportunity by Product ($ million)
Exhibits 71: Data Table on Market opportunity by Product ($ million)
Exhibits 72: Chart on End-user - Market share 2022-2027 (%)
Exhibits 73: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 74: Chart on Comparison by End-user
Exhibits 75: Data Table on Comparison by End-user
Exhibits 76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibits 87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibits 88: Market opportunity by End-user ($ million)
Exhibits 89: Data Table on Market opportunity by End-user ($ million)
Exhibits 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 91: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 93: Chart on Geographic comparison
Exhibits 94: Data Table on Geographic comparison
Exhibits 95: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 112: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 113: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 117: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 119: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 121: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 122: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 123: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 124: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 125: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 126: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 129: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 130: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 131: Market opportunity By Geographical Landscape ($ million)
Exhibits 132: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 133: Impact of drivers and challenges in 2022 and 2027
Exhibits 134: Overview on Criticality of inputs and Factors of differentiation
Exhibits 135: Overview on factors of disruption
Exhibits 136: Impact of key risks on business
Exhibits 137: Vendors covered
Exhibits 138: Matrix on vendor position and classification
Exhibits 139: AstraZeneca Plc - Overview
Exhibits 140: AstraZeneca Plc - Product/Service
Exhibits 141: AstraZeneca Plc - Key news
Exhibits 142: AstraZeneca Plc - Key offerings
Exhibits 143: Becton Dickinson and Co. - Overview
Exhibits 144: Becton Dickinson and Co. - Business segments
Exhibits 145: Becton Dickinson and Co. - Key news
Exhibits 146: Becton Dickinson and Co. - Key offerings
Exhibits 147: Becton Dickinson and Co. - Segment focus
Exhibits 148: bioMerieux SA - Overview
Exhibits 149: bioMerieux SA - Product/Service
Exhibits 150: bioMerieux SA - Key offerings
Exhibits 151: DiaSorin SpA - Overview
Exhibits 152: DiaSorin SpA - Business segments
Exhibits 153: DiaSorin SpA - Key news
Exhibits 154: DiaSorin SpA - Key offerings
Exhibits 155: DiaSorin SpA - Segment focus
Exhibits 156: F. Hoffmann La Roche Ltd. - Overview
Exhibits 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 158: F. Hoffmann La Roche Ltd. - Key news
Exhibits 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 161: Ferring BV - Overview
Exhibits 162: Ferring BV - Product/Service
Exhibits 163: Ferring BV - Key offerings
Exhibits 164: Fujirebio Holdings Inc. - Overview
Exhibits 165: Fujirebio Holdings Inc. - Product/Service
Exhibits 166: Fujirebio Holdings Inc. - Key offerings
Exhibits 167: Hologic Inc. - Overview
Exhibits 168: Hologic Inc. - Business segments
Exhibits 169: Hologic Inc. - Key news
Exhibits 170: Hologic Inc. - Key offerings
Exhibits 171: Hologic Inc. - Segment focus
Exhibits 172: Huvepharma - Overview
Exhibits 173: Huvepharma - Product/Service
Exhibits 174: Huvepharma - Key offerings
Exhibits 175: Novartis AG - Overview
Exhibits 176: Novartis AG - Business segments
Exhibits 177: Novartis AG - Key offerings
Exhibits 178: Novartis AG - Segment focus
Exhibits 179: Olympus Corp. - Overview
Exhibits 180: Olympus Corp. - Business segments
Exhibits 181: Olympus Corp. - Key news
Exhibits 182: Olympus Corp. - Key offerings
Exhibits 183: Olympus Corp. - Segment focus
Exhibits 184: Pfizer Inc. - Overview
Exhibits 185: Pfizer Inc. - Product/Service
Exhibits 186: Pfizer Inc. - Key news
Exhibits 187: Pfizer Inc. - Key offerings
Exhibits 188: QIAGEN NV - Overview
Exhibits 189: QIAGEN NV - Product/Service
Exhibits 190: QIAGEN NV - Key news
Exhibits 191: QIAGEN NV - Key offerings
Exhibits 192: Siemens AG - Overview
Exhibits 193: Siemens AG - Business segments
Exhibits 194: Siemens AG - Key news
Exhibits 195: Siemens AG - Key offerings
Exhibits 196: Siemens AG - Segment focus
Exhibits 197: Thermo Fisher Scientific Inc. - Overview
Exhibits 198: Thermo Fisher Scientific Inc. - Business segments
Exhibits 199: Thermo Fisher Scientific Inc. - Key news
Exhibits 200: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 201: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 202: Inclusions checklist
Exhibits 203: Exclusions checklist
Exhibits 204: Currency conversion rates for US$
Exhibits 205: Research methodology
Exhibits 206: Validation techniques employed for market sizing
Exhibits 207: Information sources
Exhibits 208: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global clostridium diagnostics market: AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc., Novartis AG, Olympus Corp., Pfizer Inc., QIAGEN NV, Siemens AG, Summit Therapeutics Inc., TECHLAB Inc., Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is development of new vaccines.`

According to the report, one of the major drivers for this market is the growing prevalence of CDI.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• AstraZeneca Plc
• Beckman Coulter Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• Ferring BV
• Fujirebio Holdings Inc.
• Hologic Inc.
• Huvepharma
• Meridian Bioscience Inc.
• Novartis AG
• Olympus Corp.
• Pfizer Inc.
• QIAGEN NV
• Siemens AG
• Summit Therapeutics Inc.
• TECHLAB Inc.
• Thermo Fisher Scientific Inc.
• Trinity Biotech Plc